Rigel Pharmaceuticals, Inc. (RIGL)

42.16 -1.24 (-2.86%) USD  |  NASDAQ  |  Dec 09, 15:29
More

Rigel Pharmaceuticals EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for RIGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Perspective Therapeutics, Inc. Upgrade
Nektar Therapeutics Upgrade